<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04728191</url>
  </required_header>
  <id_info>
    <org_study_id>S-20200101-b</org_study_id>
    <nct_id>NCT04728191</nct_id>
  </id_info>
  <brief_title>The Effect of Physiotherapy on Dysfunctional Breathing in Children and Adolescents With and Without Asthma</brief_title>
  <official_title>The Effect of Physiotherapy on Dysfunctional Breathing in Children and Adolescents With and Without Asthma.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kolding Sygehus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Odense Patient Data Explorative Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kolding Sygehus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate the effect of physiotherapeutical instructions on&#xD;
      dysfunctional breathing in children and adolescents with or without asthma.&#xD;
&#xD;
      Children and adolescents with dysfunctional breathing, are invited to participate in the&#xD;
      intervention study. Participants are stratified by asthma diagnose status and randomized to&#xD;
      physiotherapy or standard care. Participants are followed a year after the intervention, to&#xD;
      compare the development in asthma control ( if asthma) and quality of life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to investigate the effect of physiotherapeutical instructions on&#xD;
      dysfunctional breathing in children and adolescents with or without asthma.&#xD;
&#xD;
      All children and adolescents aged 10-17 years, followed in our outpatient clinic with the&#xD;
      diagnose of asthma are invited to fulfill the Nijmegen Questionnaire (NQ) and the Asthma&#xD;
      Control Questionnaire (ACQ5)&#xD;
&#xD;
      Children and adolescents where asthma was investigated and ruled out are invited to fulfill&#xD;
      the NQ.&#xD;
&#xD;
      Data from the electronic patient journal are used as descriptives.&#xD;
&#xD;
      Participants with dysfunctional breathing (NQ &gt;= 23) are invited to participate in the&#xD;
      intervention study. Participants are stratified by asthma diagnose status and randomized to&#xD;
      physiotherapy or standard care. Participants are followed a year after the intervention, to&#xD;
      compare the development in asthma control measured by ACQ5 (if asthma) and quality of life&#xD;
      measured by PedsQL.&#xD;
&#xD;
      The effect of physiotherapy is analyzed separately for participants with and without asthma.&#xD;
      In addition, primary outcomes are analyzed in a regression model with asthma status, age and&#xD;
      sex as explanatory variables.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 10, 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in Asthma Control Questionnaire ( ACQ5) at 6 months.</measure>
    <time_frame>ACQ is taken at baseline and 6 months after intervention as primary outcome.</time_frame>
    <description>ACQ5 contains 5 questions regarding asthma symptoms. Each question is scored between 0-6 points, where 0 represents very good asthma control and 6 represents poor asthma control. Total ACQ score is calculates as an average of points. ACQ5 is taken by participants with asthma, at visits in the outpatient clinic.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in Pediatric Quality of Life Inventory ( PedsQl) at 6 months</measure>
    <time_frame>PedsQL is taken at baseline and 6 months after intervention as primary outcome.</time_frame>
    <description>PedsQl consists of 23 questions in 4 segments ( physical functioning, emotions, social interaction, and school activities). Each question is scored from 0 (best) to 4 (worst). The PedsQl questionnairre exists in formats for young children ( not used here), children aged 8-12 years and Teenagers aged 13-18 years. Children and adolescents are answering the age relevant questionnairre at visits in the out patient clinic. The PedsQl score is transformed to a 0-100 scale as follows: 0 =100, 1=75, 2=50, 3=25, 4=0. Health related Quality of life is calculated as a mean of scores. Psychosocial Health summary score is calculated as a mean of scores in the emotional, social and school functioning scales. Physical Health summary score is calculated as physical functioning scale score mean.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Nijmegen Questionnaire ( NQ)</measure>
    <time_frame>NQ is taken at baseline and 6 weeks, 6 months and 12 months after intervention.</time_frame>
    <description>NQ consists of 16 questions regarding dysfunctional breathing. Each question is scored between 0-4 points, where 0 is best and 4 is worst.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Brompton breathing Pattern Assesment Tool ( BBPAT)</measure>
    <time_frame>BBPAT is taken at baseline and 6 weeks, 6 months and 12 months after intervention.</time_frame>
    <description>BBPAT is a breathing scoring equipment where an observer is scoring the quality of breathing from seven parameters including respiratory rate, respiratory movements, in and expiratory sounds etc. Each parameter is scored from 0 ( best) to 2 ( worst). Total score is calculated between 0-14 point</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of contacts to the hospital during one year from baseline</measure>
    <time_frame>from baseline to 12 months after intervention.</time_frame>
    <description>Number of total contacts includes planned visits, extra visits and hospitalisations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Asthma Control Questionnaire ( ACQ5) at 6 weeks and one year. Change from 6 months in ACQ at 12 months.</measure>
    <time_frame>ACQ5 is taken at 6 weeks and 12 months after intervention as secondary outcomes.</time_frame>
    <description>ACQ5 contains 5 questions regarding asthma symptoms. Each question is scored between 0-6 points, where 0 represents very good asthma control and 6 represents poor asthma control. Total ACQ score is calculates as an average of points. ACQ5 is taken by participants with asthma in the outpatient clinic at baseline and after 6 weeks, 6 months and 12 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Pediatric Quality of Life Inventory ( PedsQl) at at 6 weeks and one year. Change from 6 months in PedsQl at 12 months.</measure>
    <time_frame>PedsQl is taken at 6 weeks and 12 months after intervention as secondary outcomes.</time_frame>
    <description>PedsQl consists of 23 questions in 4 segments ( physical functioning, emotions, social interaction, and school activities). Each question is scored from 0 (best) to 4 (worst). The PedsQl questionnairre exists in formats for young children ( not used here), children aged 10-13 years and Teenagers aged 13-18 years. Children and adolescents are answering the age relevant questionnairre at visits in the out patient clinic. The PedsQl score is transformed to a 0-100 scale as follows. 0 =100, 1=75, 2=50, 3=25, 4=0. Health related Quality of life is calculated as mean of scores. Psychosocial Health summary score is calculated as mean of scores in the emotional, social and school functioning scales. Physical Health summary score is calculated physical functioning scale score mean.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The reported use of rescue Beta2 agonist in puffs per week</measure>
    <time_frame>at baseline and 6 weeks, 6 months and 12 months after intervention.</time_frame>
    <description>The reported use of short acting beta 2 agonist in puffs per week the last week.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Dysfunctional Breathing</condition>
  <condition>Asthma in Children</condition>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>+ asthma + intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>35 participants with asthma aged 10-17 years, randomized to physiotherapy. The intervention consists of 4 instruction lessons spread over 6 weeks. The participants are instructed in a daily ten-minute-program of breathing exercizes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>+ asthma - intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>35 participants with asthma aged 10-17 years, randomized to standard care. Participants are getting advice about dysfunctional breathing by a physician or nurse in the outpatient clinic.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>- asthma + intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>35 participants without asthma aged 10-17 years, randomized to physiotherapy. The intervention consists of 4 instruction lessons spread over 6 weeks. The participants are instructed in a daily ten-minute-program of breathing exercizes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>- asthma - intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>35 participants without asthma, which are randomized to standard care. Participants are getting advise about dysfunctional breathing by a physician or nurse in the outpatient clinic.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physiotherapy</intervention_name>
    <description>physiotherapeutical instructions and training as described.</description>
    <arm_group_label>+ asthma + intervention</arm_group_label>
    <arm_group_label>- asthma + intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard care</intervention_name>
    <description>Standard care as described.</description>
    <arm_group_label>+ asthma - intervention</arm_group_label>
    <arm_group_label>- asthma - intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Asthma group:&#xD;
&#xD;
          -  Asthma diagnosed by lung function tests and/or typical symptoms.&#xD;
&#xD;
          -  Treatment with inhaled corticosteroids in minimum 3 months.&#xD;
&#xD;
          -  ACQ5 &gt;= 1.5.&#xD;
&#xD;
          -  NQ &gt;= 23.&#xD;
&#xD;
        NonAsthma group&#xD;
&#xD;
          -  Asthma denied after lung function tests ( exercise challenge or mannitol challenge)&#xD;
&#xD;
          -  NQ &gt;= 23.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other significant cardiopulmonary or muscoluskeletal conditions.&#xD;
&#xD;
          -  Complex functional conditions involving other organ systems.&#xD;
&#xD;
          -  patients who already had the physotherapeutical intervention before study start.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Signe Vahlkvist, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kolding Sygehus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Signe Vahlkvist, PhD</last_name>
    <phone>+45 20 23 14 30</phone>
    <email>Signe.Vahlkvist@rsyd.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Louise J端rgensen, MD</last_name>
    <email>Anne.louise.j端rgensen@rsyd.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Signe Vahlkvist</name>
      <address>
        <city>Kolding</city>
        <zip>6000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Signe Vahlkvist, PhD</last_name>
      <email>Signe.Vahlkvist@rsyd.dk</email>
    </contact>
    <contact_backup>
      <last_name>Louise J端rgensen, MD</last_name>
      <email>Anne.louise.J端rgensen@rsyd.dk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 21, 2021</study_first_submitted>
  <study_first_submitted_qc>January 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2021</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kolding Sygehus</investigator_affiliation>
    <investigator_full_name>Signe Vahlkvist</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Dysfunctional breathing</keyword>
  <keyword>Asthma in children</keyword>
  <keyword>Asthma in adolescents</keyword>
  <keyword>Physiotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie published results, after deidentification.</ipd_description>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Beginning 3 months and ending 5 years following article publication.</ipd_time_frame>
    <ipd_access_criteria>Researchers who provide a methodologically sound proposal. Proposals should be directed to Open@rsyd.dk.</ipd_access_criteria>
    <ipd_url>http://open.rsyd.dk</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

